CDK1 and cancer: Nevertheless, inhibition by small molecules inhibiting Cdk5 and additionally Cdk1, Cdk2, Cdk7, and Cdk9 have shown promising effects in cancer/angiogenesis [18, 30, 31, 55, 56].